Probiotics Reduce Psoriasis Severity by 4 Points, Meta-Analysis of 15 RCTs

Q: What is a PASI score?

PASI (Psoriasis Area and Severity Index) measures psoriasis severity on a scale of 0 to 72, combining redness, skin thickening, scaling, and the body surface area affected. A reduction of 4 or more points is considered clinically meaningful and noticeable to the patient in daily life.

Q: Which probiotic strains work best for psoriasis?

This meta-analysis found multi-strain formulations (typically Lactobacillus and Bifidobacterium combinations) showed more consistent results than single-strain products. Probiotics alone outperformed synbiotics (probiotic plus prebiotic combinations) on PASI metrics. Optimal strain selection and dosing are not yet standardized.

Q: Can probiotics replace psoriasis medications?

The data are promising for probiotics as adjunctive support, but moderate-to-severe psoriasis is typically managed with biologics or systemic immunosuppressants as standard of care. Probiotics are best considered a complementary approach, and changes to existing treatment should be discussed with a dermatologist.

Psoriasis is a chronic inflammatory condition affecting 2~3% of the global population, driven by an immune system that mistakenly attacks the body’s own skin cells. The result is rapidly proliferating skin plaques, persistent inflammation, and significant impact on quality of life. A new meta-analysis published in ScienceDirect examines whether the gut microbiome can play a role in quieting that immune overactivation through probiotics.

The Numbers

Across 15 randomized controlled trials involving 1,423 participants, probiotics produced a mean reduction in PASI (Psoriasis Area and Severity Index) of 4.05 points (95% CI: -6.73 to -1.38, p<0.0001). The DLQI (Dermatology Life Quality Index), which captures day-to-day impact on activities, relationships, and treatment burden, dropped by a mean of 5.74 (95% CI: -11.45 to -0.03, p=0.0001). Both outcomes crossed the threshold for clinical meaningfulness, not just statistical significance.

Outperforming Systemic Drugs

The comparison data drew particular attention. Probiotics outperformed synbiotics (combined probiotic and prebiotic formulations) and, notably, performed better than some systemic pharmacological therapies including anti-TNF-α agents and anti-interleukin drugs. These biologics, used for moderate-to-severe psoriasis and rheumatoid arthritis, can cost tens of thousands of dollars annually. The fact that probiotics matched or exceeded their PASI performance in this pooled analysis is a clinically significant finding.

The Gut-Skin Axis

Probiotics influence skin inflammation through the gut-skin axis, a bidirectional communication pathway between intestinal microbiota and skin immune function. Specifically, probiotics reinforce gut barrier integrity, reducing translocation of endotoxins and pathogens into the bloodstream. They also suppress TNF-α (tumor necrosis factor-alpha) and IL-17 (interleukin-17), both of which are central mediators in psoriatic inflammation. When the gut environment stabilizes, the downstream immune response in the skin follows.

Choosing a Probiotic

Multi-strain products featuring Lactobacillus and Bifidobacterium combinations featured most consistently in the trials. Dosages ranged from 10 billion to 100 billion CFU (colony-forming units) daily. Refrigerated products tend to maintain higher viable colony counts. Market price for clinical-grade multi-strain probiotics falls in the $20~$60 per month range depending on formulation and brand.

Frequently Asked Questions

What is a PASI score? PASI (Psoriasis Area and Severity Index) measures psoriasis severity on a scale of 0 to 72 by combining redness, skin thickness, scaling, and body surface area affected. A reduction of 4 or more points is considered clinically meaningful and noticeable in daily life.

Which probiotic strains work best for psoriasis? Multi-strain formulations combining Lactobacillus and Bifidobacterium showed the most consistent results in this meta-analysis. Probiotics alone outperformed synbiotics on PASI metrics. Optimal strain and dosing protocols are not yet standardized.

Can probiotics replace psoriasis medications? The findings support probiotics as a complementary approach, but moderate-to-severe psoriasis typically requires biologics or systemic therapies as standard care. Any changes to existing treatment should be discussed with a dermatologist.

Source: ScienceDirect